Navigation Links
CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
Date:8/27/2007

blation System, is designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The Cryoablation System has been approved in Europe for the treatment of atrial fibrillation, and atrial flutter, the two most common and difficult to treat arrhythmias, since 2002. In the United States, CryoCor is conducting a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of atrial fibrillation and the Cryoablation System has been approved for the treatment of right atrial flutter. For more information please visit the Company's website at http://www.cryocor.com

Forward Looking Statements

The statements in this press release that are not descriptions of historical facts are forward-looking statements that are subject to risks and uncertainties. These include statements related to the Company's lead time over other companies conducting atrial fibrillation ablation pivotal trials, ability of obtain FDA approval for and commercialize its product for the treatment of atrial fibrillation and its timing for doing so, including its timing for the filing the related PMA, and ability to, and the benefits from, placing its systems in high volume ablation centers in the U.S., all of which are prospective. Such statements are only predictions and reflect CryoCor's expectations and assumptions as of the date of this press release based on currently available operating, financial, and competitive information. The actual events or results may differ materially from those projected in such forward-looking statements due to a number of factors, including risks involved with CryoCor's ability to obtain regulatory approval in the United States for its cryoablation system for use in treating atrial fibrillation within its anticipated timeframes, if at all; risks associated with the Company's ability to submit a PMA for atrial fibrillati
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Celsion Completes Enrollment in Phase I Liver Cancer Study
3. LANI completes Phase I in Japan and to commence Phase I in UK
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 The controversy surrounding the ... and myomectomies (procedures to remove uterine fibroids) continues, ... is investigating Johnson & Johnson,s Ethicon, Inc. unit, ... devices. According to the report published by The ... the FBI is trying to determine what the ...
(Date:5/28/2015)... May 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... Therapeutics WebcastWhen: , Thursday, June 4 at 1:00 p.m. ... , Live on the Internet.  Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
(Date:5/28/2015)... May 28, 2015   Mast Therapeutics, Inc. ... leveraging its molecular adhesion and sealant technology (MAST) ... disease, heart failure, and arterial disease, today announced ... Company,s Board of Directors. Mr. Lief made this ... given his role as President and Chief Executive ...
Breaking Medicine Technology:Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4
... SAN DIEGO, Feb. 16, 2012  Cardium Therapeutics (NYSE Amex: ... completed the previously announced sale of 17,857,143 shares of ... gross proceeds of approximately $5.0 million, before deducting placement ... and accredited investors participating in the offering purchased the ...
... Bionovo, Inc. (OTC Link Platform: BNVI.PK) a pharmaceutical company ... effective treatments for women,s health and cancer, announced today ... February 21, 2012 at 1:30 PM PST to discuss ... 31, 2011. (Logo:  http://photos.prnewswire.com/prnh/20111110/SF04662LOGO ) ...
Cached Medicine Technology:Cardium Announces Closing of $5.0 Million Equity Financing 2Cardium Announces Closing of $5.0 Million Equity Financing 3
(Date:5/28/2015)... Success Strategies for Biosimilars Approval:, ... Webinar**, June 23, 2015 — 11:00 a.m. – ... June 23, 2015, FDAnews is offering the combined ... attorneys from the international law firm Duane Morris ... A Roadmap to the 351(k) Application Process. , ...
(Date:5/28/2015)... May 28, 2015 The Boys & Girls ... from Horizon Blue Cross Blue Shield of New Jersey (Horizon ... Gulbis, the club can receive much more support as play ... , A former Boys & Girls Club member and volunteer ... California, Ms. Gulbis has accepted the Horizon Blue Cross Blue ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 AMVETS leaders ... grand prize winner Robert Davis of Newark, Del. AMVETS ... congratulate him on winning the $10,000 sweepstakes grand prize. ... over 100,000 entries from around the country for prizes ... drawing took place on May 21 at the AMVETS ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 As the summer ... to keep cool. It’s important to make safety a top ... sharing some swimming tips. , According to the Centers for ... the United States, not including boating incidents. Additionally, the National ... for children ages 1 to 4. , Amica is ...
(Date:5/28/2015)... 2015 Altima Technologies, Inc., the ... for documenting and diagramming data center assets and ... following product lines: , Manufacturer / Device ... Products N-Series TeraFrame Cabinet, Middle Atlantic Products RSH ... Systems ForeRunner, Marantz America MM Series, Extron Electronics ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2
... ... agreements, LOS ... distributor of at-home testing diagnostics,for the chronically ill, life-saving prescription drugs ... results for the first quarter period-ended March 31, 2008. Recent,highlights include:, ...
... Dr. Julie Gerberding to give keynote speech June 9 ... Gerberding,director of the U.S. Centers for Disease Control and ... health during a,keynote address at the American Water Works ... 9, in Atlanta, Georgia., As one of the ...
... to remain in Upstate New York, FLORIDA, N.Y., ... innovation in infant nutrition for more than 75 years ... nutrition in its,wide variety of products will be enhanced ... foot infant food manufacturing facility,scheduled to open in fall ...
... Who Suffered from a ,Drive-Through, Mastectomy and Signed, Lifetime,s Petition, Testifies ... ... Subcommittee Today, NEW YORK, May 21 On behalf of ... Health Subcommittee for holding the first ever hearing on the,bipartisan Breast ...
... returns to Cape Cod home while doctors determine treatment plans ... -- Sen. Edward M. Kennedy walked out of Massachusetts General ... revealed that he has a malignant brain tumor. , With ... the spot where doctors had performed a biopsy that led ...
... At the Renewal Weekend workshop in May, Deepak Chopra, M.D. and David, Simon, ... ... mind., NEW YORK, May 21 This ... Renewal Weekend, where renowned,authors, physicians, and Chopra Center co-founders, Deepak Chopra & David,Simon, ...
Cached Medicine News:Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:CDC Director to Address Public Health and Drinking Water at ACE08 2Health News:Hero/Beech-Nut's Role as an Innovation Leader Strengthened with New Infant Food Manufacturing Facility 2Health News:Hero/Beech-Nut's Role as an Innovation Leader Strengthened with New Infant Food Manufacturing Facility 3Health News:After Collecting 22 Million Petition Signatures on myLifetime.com, Bipartisan Breast Cancer Patient Protection Act Gets First Congressional Hearing in 12 Years 2Health News:Ted Kennedy Released From Hospital 2Health News:Ted Kennedy Released From Hospital 3Health News:Ted Kennedy Released From Hospital 4Health News:Ted Kennedy Released From Hospital 5Health News:The Chopra Center Co-founders Bring Mind-Body Healing to New York City 2
... designed to treat children's injuries (ages 1 to ... compression to minimize hemarthrosis and swelling, and cold ... of the cuff, it can be utilized effectively ... patient. The Pediatric Ankle Cryo/Cuff is ideal for ...
... Unique in the Cryo/Cuff line, the Knee ... is filled directly with water and ice ... ensure the optimal amount of compression, a ... after application. The cuff remains cold for ...
... immobilization following shoulder fusion, dislocation, reconstruction ... allows the shoulder to be positioned ... Following brachial plexus injury this orthosis ... stretch during the healing process and ...
OmoTrain is a unique support for the shoulder that promotes mobility and limits rotation....
Medicine Products: